Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 21.71 is 77% above its 5-year average of 12.29, near the high end of its 5-year range (7.53–21.71).
As of the fiscal period ended Tuesday, June 30, 2026. 32.06% above its 12-month average of 16.44.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 21.71.
CURRENT RATIO
21.71
CURRENT RATIO AVG TTM
16.44
CURRENT RATIO AVG 3Y
14.80
CURRENT RATIO AVG 5Y
12.29
CURRENT RATIO AVG 10Y
9.42
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+32.06%
CURRENT VS 3Y AVG
+46.63%
CURRENT VS 5Y AVG
+76.60%
CURRENT VS 10Y AVG
+130.38%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+477.36%
vs the sector median at left
Protagonist Therapeutics, Inc.
Market Cap
$8.92B
Current Ratio
21.71
TTM Avg
16.44
3Y Avg
14.80
5Y Avg
12.29
Market Cap
$8.97B
Current Ratio
1.43
TTM Avg
1.83
3Y Avg
2.46
5Y Avg
3.57
Market Cap
$8.72B
Current Ratio
9.83
TTM Avg
9.00
3Y Avg
7.15
5Y Avg
6.04
Market Cap
$8.67B
Current Ratio
5.90
TTM Avg
5.80
3Y Avg
4.63
5Y Avg
4.84
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Protagonist Therapeutics, Inc. (PTGX) | $8.92B | 21.71 | 16.44 | 14.80 | 12.29 |
| Bruker Corporation (BRKRP)vs › | $8.93B | 1.85 | 1.67 | 1.86 | 2.08 |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.97B | 1.43 | 1.83 | 2.46 | 3.57 |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.72B | 9.83 | 9.00 | 7.15 | 6.04 |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.67B | 5.90 | 5.80 | 4.63 | 4.84 |
| Bruker Corporation (BRKR)vs › | $9.21B | 1.85 | 1.67 | 1.86 | 2.08 |
| Insulet Corp. (PODD)vs › | $9.33B | 2.48 | 3.16 | 3.34 | 4.18 |
| Oscar Health, Inc. (OSCR)vs › | $8.38B | 1.08 | 0.93 | 1.08 | 1.24 |
| Vaxcyte, Inc. (PCVX)vs › | $9.63B | 5.72 | 10.33 | 12.86 | 11.45 |
| Krystal Biotech, Inc. (KRYS)vs › | $9.63B | 8.32 | 8.62 | 12.07 | 13.88 |
Current Ratio
21.71
Quick Ratio
21.71
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 21.71 |
| 2026-03-31 | 17.76 |
| 2025-12-31 | 12.71 |
| 2025-09-30 | 13.05 |
| 2025-06-30 | 16.97 |
| 2025-03-31 | 17.26 |
| 2024-12-31 | 12.48 |
| 2024-09-30 | 10.70 |
| 2024-06-30 | 13.73 |
| 2024-03-31 | 15.72 |
| 2023-12-31 | 16.71 |
| 2023-09-30 | 11.66 |
| 2023-06-30 | 12.01 |
| 2023-03-31 | 10.15 |
| 2022-12-31 | 7.80 |
| 2022-09-30 | 7.53 |
| 2022-06-30 | 7.59 |
| 2022-03-31 | 7.86 |
| 2021-12-31 | 7.74 |
| 2021-09-30 | 8.37 |
| 2021-06-30 | 8.65 |
| 2021-03-31 | 8.27 |
| 2020-12-31 | 7.84 |
| 2020-09-30 | 5.29 |
| 2020-06-30 | 6.15 |
| 2020-03-31 | 3.46 |
| 2019-12-31 | 4.10 |
| 2019-09-30 | 4.68 |
| 2019-06-30 | 4.12 |
| 2019-03-31 | 5.02 |
| 2018-12-31 | 5.26 |
| 2018-09-30 | 6.12 |
| 2018-06-30 | 4.69 |
| 2018-03-31 | 4.19 |
| 2017-12-31 | 3.55 |
| 2017-09-30 | 1.87 |
| 2017-06-30 | 7.38 |
| 2017-03-31 | 8.68 |
| 2016-12-31 | 12.94 |
| 2016-09-30 | 19.11 |
| 2016-06-30 | 5.45 |
| 2016-03-31 | 6.92 |
| 2015-12-31 | 4.54 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
